Neutralizing antibodies tested 90 days after infection were greater in participants who had been vaccinated before their ...

Despite being the leading cause of acute gastroenteritis  worldwide, there are currently no vaccines for norovirus.

Ethiopia has confirmed its first mpox cases, a 21-day old infant and the baby’s two parents, bringing the number of African ...

In a startling pandemic preparedness development, Moderna yesterday announced that US Department of Health and Human Services ...

Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral ...

Surveillance identified 7,381 candidemia cases, with an incidence of 7.4 cases per 100,000 people. Across age-groups, sexes, ...

The World Health Organization (WHO) today posted an outbreak notice about a rise in COVID activity in three of its regions, ...

Long-COVID symptoms were based on caregiver-reported symptoms lasting at least 90 days after COVID infections; in total 41 ...

A survey of Medicare-certified home healthcare (HHC) agencies reveals minor improvements and problematic declines in ...

The Swiss drugmaker says the safety and efficacy of zosurabalpin will be investigated in a study involving 400 patients with ...

Debiopharm initially received funding from CARB-X in 2017 for pre-clinical development of Debio1453, which inhibits an ...